Indian pharma major Strides Pharma Science has announced a significant Strides Pharma Africa expansion by acquiring a portfolio of branded generic medicines from Sandoz AG.
Pfizer Inc. today reported positive topline findings from its Phase 2 FOURLIGHT-1 trial, marking a key milestone in the atirmociclib breast cancer study for patients with HR-positive HER2-negative metastatic breast cancer...
Ajanta Pharma, Sun Pharma, and Lupin are in focus as Ozempic Patent Expiry drives surge in pharma stocks ahead of launch, with companies gearing up for semaglutide generics in the fast-growing diabetes and weight-loss market.
Bharat Biotech is advancing vaccines to fight drug resistance, focusing on preventing hospital infections and reducing antibiotic use as antimicrobial resistance grows into a major global health threat.
Union Minister Jitendra Singh lays foundation for Rs 600 crore pharmaceutical facility in Kathua to boost India’s self-reliance in critical antibiotic manufacturing and reduce import dependence.
AstraZeneca Pharma India has received regulatory approval for Durvalumab for liver cancer treatment in India, marking a significant step in expanding cancer care options.
Zydus Lifesciences has partnered with Lupin to roll out its weight loss injection in India, expanding access to semaglutide in India for diabetes and obesity treatment as demand rises across the country.
.png "Ebglyss by Eli Lilly Shows Strong Results in Pediatric Dermatitis")
Eli Lilly and Company reports strong Phase 3 data for Ebglyss, showing major skin improvement and itch relief in children with moderate-to-severe atopic dermatitis.
Sun Pharma moves closer to expanding Ilumya’s use as the US FDA begins reviewing its application for psoriatic arthritis, backed by late-stage trial data showing promising results.
.png "Alkem Laboratories Gets Germany GMP Certificate for Baddi Plant")
Alkem Laboratories’ Baddi manufacturing facility in India receives Germany GMP certificate, validating compliance with international quality standards and boosting its global pharmaceutical presence.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")